This inventor holds 7 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Bridge Pharma Inc.. Active years: 2001-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Worcester, MA (US) (2001 - 2002)
- Shrewsbury, MA (US) (2006 - 2011)
Company Filing History:
Years Active: 2001-2011
Title: **Innovative Contributions of Jan L. Chen in Antiallergic Drug Development**
Introduction
Jan L. Chen, based in Shrewsbury, MA, is a prominent inventor renowned for her significant contributions to pharmaceutical advancements. With a total of seven patents to her name, she is particularly recognized for her innovative work on optically active isomers of ketotifen and their therapeutically active metabolites. These innovations are poised to redefine treatment options in allergy and inflammation.
Latest Patents
Chen's latest patents focus on the development of racemic norketotifen, racemic 10-hydroxy-ketotifen, and racemic 10-hydroxy-nor-ketotifen, along with their optically active isomers. These compounds have been evidenced to exhibit antiallergic and anti-inflammatory properties while minimizing the severe dose-limiting sedative side effects commonly associated with ketotifen. This groundbreaking research addresses a critical need in the pharmaceutical industry for safer treatment alternatives.
Career Highlights
Jan L. Chen is currently associated with Bridge Pharma Inc., where she continues to advance her research. Her dedication to innovation in the field of pharmaceuticals has led her to achieve multiple patents that showcase her expertise in drug development. Her work not only highlights her skill as an inventor but also her commitment to improving patient health outcomes.
Collaborations
Throughout her career, Chen has collaborated with esteemed colleagues such as A K Gunnar Aberg and George Edward Wright. These partnerships have been instrumental in the progress of her research and the successful completion of her innovative projects, combining their expertise to enhance the development of new therapeutic agents.
Conclusion
Jan L. Chen’s work exemplifies the impact of innovative thinking and collaboration in the field of pharmaceuticals. As she continues to build upon her research and patent portfolio, her contributions promise to advance medical science, particularly in the domain of allergy and inflammatory treatment. Her journey is an inspiration for aspiring inventors and highlights the importance of pursuing new solutions to existing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile